Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins-Reference-Cited by-同舟云学术

Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins

Published:2017-10 Issue:10 Volume:106 Page:2946-2954
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Hamuro Lora,Kijanka Grzegorz,Kinderman Francis,Kropshofer Harald,Bu De-xiu,Zepeda Monica,Jawa Vibha

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference99 articles.

1. Clinical pharmacokinetics of therapeutic monoclonal antibodies;Keizer;Clin Pharm,2010

2. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies;Mitragotri;Nat Rev Drug Discov,2014

3. Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study;Fallowfield;Breast,2015

4. Subcutaneous trastuzumab for HER2-positive breast cancer - evidence and practical experience in 7 German centers;Jackisch;Geburtshilfe Frauenheilkd,2015

5. Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study;North;Clinicoecon Outcomes Res,2015

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity;Clinical Immunology;2024-10

2. Recent approaches of antibody therapeutics in androgenetic alopecia;Frontiers in Pharmacology;2024-08-16

3. Impact of hydrophobic modification on biocompatibility of Alaska pollock gelatin microparticles;Analytical Sciences;2024-08-09

4. Double hit — bispecific antibodies in cancer therapy;Oncology in Clinical Practice;2024-05-31

5. Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route;The AAPS Journal;2024-05-10